Patents by Inventor Ran JING

Ran JING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260199470
    Abstract: Provided herein are T cell receptors (TCRs) or antigen-binding fragments thereof, such as those that recognize or bind a relatively hematopoietically-restricted minor histocompatibility antigen, e.g., HA-2. In particular, the present disclosure relates to TCRs that bind or recognize particular HA-2 peptides in the context of a major histocompatibility complex (MHC) molecule. The present disclosure further relates to nucleic acids encoding such TCRs, engineered cells comprising such TCRs, methods of isolating such TCRs, and uses thereof, for example, in cell therapy.
    Type: Application
    Filed: November 28, 2023
    Publication date: July 16, 2026
    Inventors: Erik Martin, Mark Shlomchik, Warren David Shlomchik, Sawa Ito, Constantinos Panousis, Andrew Bellesis, Autumn Toki, Kiera Regan, Ran Jing, Joe Baker, Jaeung Jang
  • Publication number: 20260015582
    Abstract: The technology described herein is directed to improved methods of T cell differentiation. Also described herein are immune cells differentiated using such methods and compositions comprising such immune cells. In some embodiments, the immune cells can be genetically modified. In some embodiments, the immune cells or compositions comprising said immune cells can be administered to a patient as a cellular replacement therapy to treat a condition.
    Type: Application
    Filed: July 18, 2023
    Publication date: January 15, 2026
    Applicant: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: George Q. DALEY, Ran JING
  • Publication number: 20250092494
    Abstract: Provided are a high-plasticity dual-phase high-entropy alloy (HEA) and a preparation method thereof. The high-plasticity dual-phase HEA has a chemical formula as shown in Formula I: (FeCoNiCr)100-xTix (Formula I), in which, x is in a range of 2.0 to 2.8. A method for preparing the high-plasticity dual-phase HEA is also provided.
    Type: Application
    Filed: July 13, 2023
    Publication date: March 20, 2025
    Applicant: SHAANXI UNIVERSITY OF TECHNOLOGY
    Inventors: Ran JING, Xiong ZHANG, Qing ZHANG, Taotao AI, Jianghua LI, Pengfei CHUI, Yang ZHANG, Zhongni LIAO
  • Publication number: 20240295013
    Abstract: The present disclosure provides a high-entropy alloy (HEA) with room-temperature superplasticity and a preparation method thereof, belonging to the field of metal materials. In the present disclosure, the HEA with room-temperature superplasticity has a chemical formula shown in Formula I: (FeCoNiCr)100-xCux (Formula I), where in Formula I, x is 2.0 to 4.0. A FeCoNiCr alloy is used as a matrix, and then added with a trace amount of a Cu element, thereby significantly reducing formation of a metastable phase in the FeCoNiCr alloy while reducing stacking fault energy of the alloy, such that the alloy maintains a desirable work hardening ability and achieves an excellent elongation at break. Moreover, a plasticity of the alloy is further improved through twinning-induced plasticity (TWIP).
    Type: Application
    Filed: January 26, 2024
    Publication date: September 5, 2024
    Applicant: Shaanxi University of Technology
    Inventors: Ran JING, Xiong ZHANG, Qing ZHANG, Taotao AI, Jianghua LI, Pengfei CHUI, Yang ZHANG, Zhongni LIAO
  • Publication number: 20240158750
    Abstract: The technology described herein is directed to stromal-free methods of NK cell differentiation. Also described herein are cells differentiated using stromal-free methods and compositions comprising such cells. In some embodiments, the cells can be genetically modified. In some embodiments, the cells or compositions comprising said cells can be administered to a patient to treat cancer or as a cellular replacement therapy to treat a condition.
    Type: Application
    Filed: March 4, 2022
    Publication date: May 16, 2024
    Applicant: The Children's Medical Center Corporation
    Inventors: Ran Jing, Georg Q. Daley
  • Publication number: 20230073449
    Abstract: The technology described herein is directed to stromal-free methods of T cell differentiation. Also described herein are immune cells differentiated using stromal-free methods and compositions comprising such immune cells. In some embodiments, the immune cells can be genetically modified. In some embodiments, the immune cells or compositions comprising said immune cells can be administered to a patient as a cellular replacement therapy to treat a condition.
    Type: Application
    Filed: January 22, 2021
    Publication date: March 9, 2023
    Applicant: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: George Q. DALEY, Ran JING
  • Patent number: 10939230
    Abstract: Embodiments of this application disclose an interaction information obtaining method performed at a target user terminal. After detecting, on a virtual map preset in an interaction application, a trigger operation performed on a target POI identifier, the target user terminal obtains first location information of the target user terminal by using the virtual map and second location information corresponding to the target POI identifier on the virtual map. The target user terminal detects a distance difference between the first location information and the second location information. When the distance difference satisfies a preset distance range, the target user terminal sends, to an interaction server, an interaction information request carrying the target POI identifier and receives interaction information corresponding to the target POI identifier from the interaction server and then displays the interaction information on the virtual map.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: March 2, 2021
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Yang Mo, Yecheng Xian, Ling Liu, Yu Zhang, Ran Jing, Liqiang Liu, Huayu Sun, Zhi Yuan, Bosheng Lei, Fang Wang
  • Publication number: 20190281411
    Abstract: Embodiments of this application disclose an interaction information obtaining method performed at a target user terminal. After detecting, on a virtual map preset in an interaction application, a trigger operation performed on a target POI identifier, the target user terminal obtains first location information of the target user terminal by using the virtual map and second location information corresponding to the target POI identifier on the virtual map. The target user terminal detects a distance difference between the first location information and the second location information. When the distance difference satisfies a preset distance range, the target user terminal sends, to an interaction server, an interaction information request carrying the target POI identifier and receives interaction information corresponding to the target POI identifier from the interaction server and then displays the interaction information on the virtual map.
    Type: Application
    Filed: May 29, 2019
    Publication date: September 12, 2019
    Inventors: Yang MO, Yecheng XIAN, Ling LIU, Yu ZHANG, Ran JING, Liqiang LIU, Huayu SUN, Zhi YUAN, Bosheng LEI, Fang Wang